{
    "2020-05-12": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Novartis Stock Shows Rising Relative Strength; Mostly V-Shape Recovery From Covid Crash",
                "features": {
                    "keywords": [
                        "Novartis",
                        "rising relative strength",
                        "V-shape recovery",
                        "Covid crash"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Biotech Amgen Is Tackling Coronavirus From Two Sides â€” But Is It A Buy?",
                "features": {
                    "keywords": [
                        "Biotech",
                        "Amgen",
                        "Coronavirus",
                        "two sides",
                        "buy"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}